EBR Systems' (ASX:EBR) WiSE system was accepted into the Centers for Medicare & Medicaid Services' Transitional Coverage for Emerging Technologies reimbursement pathway, according to a Monday filing with the Australian bourse.
WiSE technology is a wireless pacing system designed to stimulate the heart's left ventricle.
The pathway is designed to expedite Medicare coverage for a select group of breakthrough devices designated by the US Food and Drug Administration, enabling early access to innovative medical technologies, the filing said.
Shares rose nearly 1% in midday trade Monday and earlier reached an all-time high.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。